Source: Annual Congress 2004 - Diagnosis and epidemiology of respiratory infections in the ICU
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. V. Shilova, T. I. Martynenko, S. V. Shabanova, M. P. Bukhtoiarov, A. V. Markin (Barnaul, Russia). The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis. Eur Respir J 2004; 24: Suppl. 48, 3399

Member's Comments

No comment yet.

Related content which might interest you: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Effects of empirical antibacterial therapy on the degree of systemic inflammatory response in patients with severe community-acquired pneumonia (SCAP) Source: Eur Respir J 2003; 22: Suppl. 45, 2s Year: 2003 Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006 The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 733s Year: 2006 Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Source: Eur Respir J 2006; 27: 158-164 Year: 2006 Compliance with severe sepsis bundles and its effect on outcomes of severe pneumonia and septic shock in a Chinese hospital Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Effect of antibiotic prophylaxis on pneumonia in cardiac arrest patients treated with therapeutic hypothermia Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia Source: Eur Respir J 2009; 33: 521 Year: 2009 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 The ability of pro adrenomedullin to predict severe sepsis in patients with comunity-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004